0001819790-25-000055.txt : 20250320 0001819790-25-000055.hdr.sgml : 20250320 20250320214834 ACCESSION NUMBER: 0001819790-25-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250318 FILED AS OF DATE: 20250320 DATE AS OF CHANGE: 20250320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Azamian Bobak R. CENTRAL INDEX KEY: 0001827672 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39614 FILM NUMBER: 25758372 MAIL ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD, SUITE 160 CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001819790 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 814717861 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: (949) 409-9820 MAIL ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 4 1 wk-form4_1742521708.xml FORM 4 X0508 4 2025-03-18 0 0001819790 Tarsus Pharmaceuticals, Inc. TARS 0001827672 Azamian Bobak R. C/O TARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618 1 1 0 0 President/CEO and Board Chair 0 Common Stock 2025-03-18 4 S 0 7131 46.29 D 70720 D Common Stock 2025-03-19 4 S 0 8551 47.40 D 62169 D Common Stock 2025-03-20 4 S 0 8534 50.11 D 53635 D Common Stock 830106 I By the Bobak Azamian Living Trust established April 16, 2018 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. /s/ Jeffrey Farrow, Attorney-in-Fact 2025-03-20